Dr. Andrei Alexandrov received his MD degree in 1989 from the 1st Moscow Medical Institute (Sechenov), and specialized in clinical neurology at the Institute of Neurology, Russian Academy of Medical Sciences, Moscow, Russia. He completed his fellowship training in stroke and cerebrovascular ultrasound at the University of Toronto with Dr John W. Norris and at the University of Texas with Dr James C. Grotta, and also received mentoring from Drs Dmitry K. Lunev, Patrick M. Pullicino and Sandra E. Black.

Dr. Alexandrov published 213 original papers, 3 textbooks, 16 case reports, 149 review articles, editorials, invited publications, and book chapters & over 310 abstracts presented at major scientific meetings and published in refereed journals. Current h-factor 62.

Dr. Alexandrov has trained 50 fellows in cerebrovascular ultrasound and stroke. He serves as Director of the Neurosonology Examination, Program Committee Chair and President-Elect of the American Society of Neuroimaging, Board member of the Intersocietal Accreditation Commission (IAC-Vascular), founding Editor-in-Chief (2011-2015), Brain and Behavior, Editorial Board member of Stroke, Cerebrovascular Diseases, International Journal of Stroke, Journal of Neuroimaging, The Stroke Interventionalist, and Annaly Klinicheskoi I Experimentalnoi Nevrologii and past member of the Society of Vascular and Internional Neurology (SVIN) Board of Directors, and Program Committee, International Stroke Conference of the American Heart Association. He is an active elected member of the American Neurological Association.

Dr. Alexandrov holds a US patent and specializes in development of novel reperfusion therapies for stroke. He also serves as Medical Director of Mobile Stroke Unit, first in the world with state-of-the-art CT scanner performing head and neck CTA, and he also directs Memphis City-wide Stroke Program that achieved the highest treatment rates with tPA in the world in 2015-2017.